Oshi Health Expands Series C Funding to $60 Million, Enhancing Virtual Gastrointestinal Care

Oshi Health, a pioneering digital health company specializing in virtual gastrointestinal (GI) care, has announced an expansion of its Series C funding round, bringing the total to $60 million. This significant investment underscores the growing recognition of the importance of accessible, comprehensive GI care and positions Oshi Health to further enhance its innovative virtual platform.

Funding Details and Key Investors

The Series C funding round was led by Oak HC/FT, with participation from existing investors Bessemer Venture Partners, Flare Capital Partners, Frist Cressey Ventures, CVS Health Ventures, and Takeda Digital Ventures. Notably, the American College of Gastroenterology (ACG) and the American Gastroenterological Association (AGA) GI Opportunity Fund, along with a group of prominent practicing physicians, have also joined this round, highlighting the medical community's confidence in Oshi Health's approach.

Oshi Health's Mission and Services

Founded in 2018 and based in New York, Oshi Health operates as a virtual center specializing in digestive healthcare. The company provides comprehensive gastroenterology services, including diagnosis and treatment of GI symptoms and conditions, supported by a multidisciplinary team of specialists. Oshi Health serves members of health plans, offering care that integrates dietary and behavioral health support.

Impact and Future Plans

With the additional funding, Oshi Health plans to expand its reach and impact, bringing its proven hybrid care model to more patients across the country. The company's multidisciplinary team includes specialized advanced practice providers, registered dietitians, behavioral health providers, board-certified gastroenterologists, and dedicated care coordinators. This integrated approach ensures that patients receive comprehensive care that addresses all aspects of their digestive health, including medical, nutritional, and psychological factors.

Conclusion

Oshi Health's expanded Series C funding round marks a significant milestone in the company's mission to revolutionize GI care through innovative virtual solutions. With strong support from leading investors and the medical community, Oshi Health is well-positioned to enhance patient outcomes and access to specialized GI care across the United States.